Magazine
ENEWS
SUBSCRIBE
WEBINARS
PODCASTS
EBOOKS
Edit submissions
Press releases
Media kit
Innovation Awards
Industry News
Royalty Pharma Aims to Buy Elan for $6.5 Billion
Feb. 27, 2013
RP Management LLC, an investor in royalty streams from pharmaceuticals, offered to buy Elan Corp. for about $6.5 billion, threatening the Irish drugmaker’s plan to embark on its own acquisitions.
Read the full story here.
Latest from Industry News
Pfizer to let go of 791 employees at NJ site
Novartis completes Sandoz spin-off
Gritstone wins BARDA bid for next-gen COVID vax
Kinnate to let go of 70% of employees
Load More Content